Jobs filters
POSTDOCTORAL FELLOW - NK CELLS AND RNA MODIFICATIONS - 10027891
Duarte, CACity of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases.
Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a wholly owned subsidiary, was launched in 2019 and is dedicated to serving employers and their health care partners by providing access to City of Hope’s exceptional cancer expertise.
A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report and received Magnet Recognition from the American Nurses Credentialing Center. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona.
Join the forefront of groundbreaking research at the Beckman Research Institute of City of Hope, where we're changing lives and making a real difference in the fight against cancer, diabetes, and other life-threatening illnesses. Our dedicated and compassionate faculty and staff are driven by a common mission: Contribute to innovative approaches in predicting, preventing, and curing diseases, shaping the future of medicine through cutting-edge research.
The City of Hope National Medical Center is looking for a highly motivated and creative Postdoctoral Fellow to work in either of the following areas within the laboratory of Dr. Shoubao Ma, an Assistant Professor in the Department of Hematology and Hematopoietic Cell Transplantation and Comprehensive Cancer Center: 1) Natural Killer (NK) cell immunity, including the proliferation, survival, function, and exhaustion of NK cells, and develop NK or CAR NK cell-based therapies for cancer, autoimmune disorders, and inflammatory diseases 2) RNA modifications in immunity, including RNA Modifications in Immune Cell Homeostasis and Fate Decisions, RNA Modifications in Tumor Immune Evasion. The group conducts the most forefront science and is highly productive with publications in high-impact journals such as Nature Immunology, Cancer Discovery, Science Immunology, JEM, PNAS, etc. in the past five years.
For more information about Dr. Ma’s lab, please visit here.
As a successful candidate, you will:
- Devise, plan, document and advance basic science and translational projects in the relevant research area.
- Collect data for grant applications and prepare manuscripts for publication.
- Work in close collaboration with other team members and external partners.
- Train and supervise technical staff.
- You will have the unique possibility to drive research towards a novel cancer therapy at the interface of science and translation to the clinic and publish high-impact journals.
Your qualifications should include:
- Recent PhD with a strong background and profound knowledge in the field of either immunology, cancer immunology or immunotherapy.
- Previous experience in working with animal models, immunological assays, CRISPR screen, drug screen, and genomic assays (RNA-seq, m6A-seq, ChIP-seq, etc.)
- Literature knowledge of one of the two research areas mentioned above.
- Evidence of scientific rigor and excellence as documented by high-impact peer-reviewed publications.
- Strong team player with excellent communication skills and fluency in English, both spoken and written.
City of Hope is an equal opportunity employer. To learn more about our commitment to diversity, equity and inclusion, please click here.
To learn more about our Comprehensive Benefits, please CLICK HERE.
#PD